JPRN-UMIN000017037已完成3 期
The study for the effect of intravitreous injection of ranibizumab (product name: Lucentis) and subthreshold laser photocoagulation on diabetic macular edema - The study for the effect of combination therapy of intravitreous injection of ranibizumab and subthreshold laser photocoagulation on diabetic macular edema
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who receive occular surgical treatments within 3 months Patients who receive other macular diseases
研究者
相似试验
已完成
2 期
Intravitreal injection of methotrexate in persistent diabetic macular edemaResistant macular edema in diabetic patients.Distrubtion of retinal layers due to edemaIRCT201610098983N2Guilan University of Medical Sciences,Vice chancellor for research42
招募中
1 期
Comparison of the effect of intravitreal injection of bevacizumab (Stevenet) alone with intravitreal injection of bevacizumab and triamcinolone in the treatment of diabetic macular edema with a thickness greater than 500 microns in patientsIRCT20211130053229N1Kerman University of Medical Sciences70
招募中
1 期
Investigating the effect of mesenchymal stem cell injection on reducing complications in patients with liver cirrhosisReducing complications of liver failure in patients with decompensated liver cirrhosis.Congenital cirrhosis (of liver)P78.81IRCT20140911019125N11Kerman University of Medical Sciences10
进行中（未招募）
不适用
Funktionelle Ergebnisse der intravitrealen Injektion von Triamcinolonacetonid im Vergleich zur konventionellen Lasertherapie bei diabetischem Makulaödem. - DME-TAEUCTR2004-005197-23-DEKlinik und Poliklinik für Augenheilkunde der Universität Regensburg40
已完成
不适用
complications of injection given in the eye for retinal diseasesCTRI/2015/10/006250ETHRADHAMA SUPERSPECIALITY EYE HOSPITA100